5 Trends to Watch in the Liquid Biopsy Market

5 Trends to Watch in the Liquid Biopsy Market

The liquid biopsy market is experiencing four trends driving growth, and one trend that should be watched as a limited trend.


IBM Watson Health and Quest Diagnostics’ Bid to Advance Clinical Sequencing Informatics

IBM Watson Health and Quest Diagnostics’ Bid to Advance Clinical Sequencing Informatics

With next-generation sequencing (NGS), research scientists and clinicians are provided abundant raw data, but also too often deficient analytics software also known as informatics. Vendor-specific sequencing informatics software has limited access to third-party research discoveries in genomics. Sequencing analytics already in the clinical field may struggle to remain current with quickly evolving understanding of the genomic, epigenomic and transcriptomic underpinnings in cancer.


Tech Giants Become Big Movers in Medical Research

Tech Giants Become Big Movers in Medical Research

Basic research is fundamental to the introduction of medicine, medical technologies and other marketable healthcare products. Its bewildering scope or the experimental freedom necessary for market-significant discoveries requires tremendous resources with relative inattention to profitability or return. If pharmaceuticals, medical devices and diagnostics are what emerge from the spigot of translational research workflows, basic research is the well - continually being dug deeper to access wider ...


QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

QIAGEN Bolsters Presence in Clinical NGS and Cancer Diagnostics Markets with GeneReader System Launch

Kalorama Information provides further analysis of QIAGEN and its competitors, including the companies’ cancer diagnostics and NGS product portfolios, in recent market research reports The World Market for Cancer Diagnostics, 6 th Edition ; Library Preparation and Target Enrichment for Next Generation Sequencing Product Markets ; and Next Generation Sequencing Markets.

Several years of technology acquisition and internal development have culminated for QIAGEN with the launch of its comprehensiv...